| Literature DB >> 36172412 |
Seung Jun Song1, Wan Kee Kim1, Tae-Hoon Kim2, Suk-Won Song2.
Abstract
Objectives: To compare unilateral versus bilateral antegrade cerebral perfusion (ACP) techniques on cerebral protection during acute type A aortic dissection repair.Entities:
Keywords: ACP, antegrade cerebral perfusion; ATAAD, acute type A aortic dissection; CPB, cardiopulmonary bypass; CT, computed tomography; PND, permanent neurologic deficit; TCA, total circulatory arrest; TND, transient neurologic deficit; aortic dissection; cerebral protection; selective cerebral perfusion
Year: 2022 PMID: 36172412 PMCID: PMC9510789 DOI: 10.1016/j.xjon.2022.05.006
Source DB: PubMed Journal: JTCVS Open ISSN: 2666-2736
Figure 1Unadjusted Kaplan-Meier plot for survival rates depending on the types of anterior cerebral perfusion techniques. Solid red line indicates unilateral group; dashed blue line indicates bilateral group. Shaded bands indicate areas within 95% CIs. Bi-ACP, Bilateral antegrade cerebral perfusion; Uni-ACP, unilateral antegrade cerebral perfusion; HR, hazard ratio; CI, confidence interval.
Figure 2Propensity score-matched Kaplan-Meier plot for survival rates depending on the types of anterior cerebral perfusion techniques. Solid red line indicates unilateral group; dashed blue line indicates bilateral group. Shaded bands indicate areas within 95% CI. Bi-ACP, Bilateral antegrade cerebral perfusion; Uni-ACP, unilateral antegrade cerebral perfusion; HR, hazard ratio; CI, confidence interval.
Details of patients and surgery depending on the interquartile surgical periods
| Detail | Interquartile range | ||||
|---|---|---|---|---|---|
| First | Second | Third | Fourth | ||
| Years of index surgery | 2008-2012 | 2012-2015 | 2015-2018 | 2018-2019 | |
| No. of patients | 130 (24.9) | 130 (24.9) | 131 (25.1) | 131 (25.1) | |
| Baseline characteristic | |||||
| Age (y) | 61.7 ± 14.9 | 59.4 ± 13.7 | 59.1 ± 14.5 | 63.4 ± 16.1 | .42 |
| Male gender | 66 (50.8) | 61 (46.9) | 59 (45.0) | 66 (50.4) | .75 |
| Types of aortic dissection | .12 | ||||
| DeBakey type 1 | 104 (80.0) | 108 (83.1) | 106 (80.9) | 94 (71.8) | |
| DeBakey type 2 | 26 (20.0) | 22 (16.9) | 25 (19.1) | 37 (28.2) | |
| Cerebral perfusion technique | <.001 | ||||
| Unilateral | 74 (56.9) | 92 (70.8) | 96 (73.3) | 116 (88.5) | |
| Bilateral | 56 (43.1) | 38 (29.2) | 35 (26.7) | 15 (11.5) | |
| Details of surgery | |||||
| Arch surgery | <.001 | ||||
| 1-partial arch replacement | 21 (16.2) | 20 (15.4) | 33 (25.2) | 6 (4.6) | |
| 2-partial arch replacement | 28 (21.5) | 21 (16.2) | 39 (29.8) | 49 (37.4) | |
| Total arch replacement | 38 (29.2) | 53 (40.8) | 48 (36.6) | 73 (55.7) | |
| Root surgery | .34 | ||||
| None | 119 (91.5) | 120 (92.3) | 114 (87.0) | 114 (87.0) | |
| Bentall operation | 10 (7.7) | 10 (7.7) | 12 (9.2) | 9 (6.9) | |
| Valve-sparing techniques | 1 (0.8) | 0 | 5 (3.8) | 8 (6.1) | |
| Graft insertion into DTA | 7 (5.4) | 23 (17.8) | 5 (3.8) | 16 (12.2) | <.001 |
Values are presented as range, n (%), or mean ± SD. DTA, Descending thoracic aorta.
Baseline characteristics depending on the type of cerebral perfusion technique (intention-to-treat groups)
| Characteristic | Overall cohort | Propensity score-matched cohort | ||||||
|---|---|---|---|---|---|---|---|---|
| Unilateral (n = 378) | Bilateral (n = 144) | STD | Unilateral (n = 94) | Bilateral (n = 94) | STD | |||
| Age (y) | 60.6 ± 15.3 | 61.8 ± 13.8 | .42 | 0.66 | 61.8 ± 14.2 | 62.2 ± 14.0 | .86 | 0.03 |
| Male gender | 177 (46.8) | 75 (52.1) | .33 | 0.11 | 42 (44.7) | 46 (48.9) | .66 | 0.09 |
| Hypertension | 231 (61.1) | 92 (63.9) | .63 | 0.18 | 55 (58.5) | 61 (64.9) | .45 | 0.13 |
| Diabetes mellitus | 40 (10.6) | 7 (4.9) | .06 | 0.22 | 6 (6.4) | 6 (6.4) | >.99 | 0 |
| Cerebrovascular disease | 23 (6.1) | 16 (11.1) | .08 | 0.18 | 11 (11.7) | 7 (7.4) | .46 | 0.14 |
| Chronic renal failure | 14 (3.7) | 4 (2.8) | .80 | 0.05 | 3 (3.2) | 2 (2.1) | >.99 | 0.07 |
| COPD | 6 (1.6) | 3 (2.1) | .99 | 0.04 | 1 (1.1) | 2 (2.1) | >.99 | 0.09 |
| Coronary arterial disease | 15 (4.0) | 8 (5.6) | .58 | 0.07 | 6 (6.4) | 5 (5.3) | >.99 | 0.05 |
| Marfan | 24 (6.3) | 9 (6.2) | >.99 | 0.004 | 6 (6.4) | 5 (5.3) | >.99 | 0.05 |
| DeBakey type 1 | 301 (79.6) | 111 (77.1) | .61 | 0.06 | 81 (86.2) | 73 (77.7) | .19 | 0.22 |
| DeBakey type 2 | 77 (20.4) | 33 (22.9) | .61 | 0.06 | 13 (13.8) | 21 (22.3) | .19 | 0.22 |
| Intramural hematoma | 80 (21.2) | 26 (18.1) | .51 | 0.08 | 18 (19.1) | 17 (18.1) | >.99 | 0.03 |
| Hemopericardium | 132 (34.9) | 53 (36.8) | .76 | 0.04 | 31 (33.0) | 31 (33.0) | >.99 | 0 |
| Details of surgery | ||||||||
| Arch surgery | <.001 | 0.55 | .36 | 0.02 | ||||
| 1-partial arch replacement | 65 (17.2) | 15 (10.4) | 17 (18.1) | 9 (9.6) | ||||
| 2-partial arch replacement | 110 (29.1) | 27 (18.8) | 22 (23.4) | 25 (26.6) | ||||
| Total arch replacement | 166 (43.9) | 46 (31.9) | 36 (38.3) | 36 (38.3) | ||||
| Root surgery | >.99 | 0.005 | .80 | 0.07 | ||||
| None | 338 (89.4) | 129 (89.6) | 84 (89.4) | 86 (91.5) | ||||
| Bentall's operation | 29 (7.7) | 12 (8.3) | 8 (8.5) | 5 (5.3) | ||||
| Valve sparing techniques | 11 (2.9) | 3 (2.1) | 2 (2.1) | 3 (3.2) | ||||
| Graft insertion in DTA | 41 (10.8) | 10 (7.0) | .38 | 0.19 | 13 (13.8) | 6 (6.4) | .23 | 0.25 |
Values are presented as mean ± SD or n (%). STD, Standardized mean difference; COPD, chronic obstructive pulmonary disease; DTA, descending thoracic aorta.
Surgical periods and attending surgeons of the patients who received unilateral or bilateral antegrade cerebral perfusion techniques (intention-to-treat groups)
| Variable | Overall cohort | Propensity score-matched cohort | ||||||
|---|---|---|---|---|---|---|---|---|
| Unilateral (n = 378) | Bilateral (n = 144) | STD | Unilateral (n = 94) | Bilateral (n = 94) | STD | |||
| Years at operation | <.001 | 0.66 | .65 | 0.04 | ||||
| Quartile range 1 | 74 (19.6) | 56 (38.9) | 26 (27.7) | 31 (33.0) | ||||
| Quartile range 2 | 92 (24.3) | 38 (26.4) | 28 (29.8) | 21 (22.3) | ||||
| Quartile range 3 | 96 (25.4) | 35 (24.3) | 24 (25.5) | 27 (28.7) | ||||
| Quartile range 4 | 116 (30.7) | 15 (10.4) | 16 (17.0) | 15 (16.0) | ||||
| Surgeon | <.001 | 0.57 | .85 | 0.08 | ||||
| A | 367 (97.1) | 104 (72.2) | 86 (91.5) | 88 (93.6) | ||||
| B | 7 (1.9) | 33 (22.9) | 5 (5.3) | 4 (4.3) | ||||
| C | 4 (1.1) | 7 (4.9) | 3 (3.2) | 2 (2.1) | ||||
Values are presened as n (%). STD, Standardized mean difference.
Achieved body temperature and operation-related times for patients who received unilateral or bilateral antegrade cerebral perfusion (ACP) techniques (intention-to-treat groups)
| Variable | Overall cohort | Propensity score-matched cohort | ||||||
|---|---|---|---|---|---|---|---|---|
| Unilateral (n = 378) | Bilateral (n = 144) | STD | Unilateral (n = 94) | Bilateral (n = 94) | STD | |||
| Body temperatures during ACP | ||||||||
| Esophagus | 22.7 (20.3-24.3) | 23.6 (21.4-25.3) | .004 | 0.28 | 23.9 (22.0-25.2) | 23.9 (22.1-25.2) | .32 | 0.15 |
| Rectum | 27.8 (26.7-28.4) | 27.4 (26.6-28.0) | .002 | 0.27 | 27.5 (26.7-28.0) | 27.7 (27.0-28.1) | .09 | 0.25 |
| Additional ACP (conversion) | 21 (5.6) | 0 | 7 (7.4) | 0 | ||||
| Operation time (min) | ||||||||
| Total bypass time | 154 (133-186) | 182 (154-221) | <.001 | 0.53 | 172 (136-214) | 155 (131-189) | <.001 | 0.58 |
| Cardiac ischemia | 63 (48-82) | 70 (52-100) | .03 | 0.22 | 59 (43-80) | 56 (44-76) | .03 | 0.32 |
| Lower body ischemia | 44 (35-53) | 51 (42-62) | <.001 | 0.36 | 41 (32-56) | 43 (35-56) | <.001 | 0.59 |
Values are presented as mean (interquartile range) or n (%). STD, Standardized mean difference.
Crude early clinical outcomes depending on the type of cerebral perfusion technique (intention-to-treat groups)
| Overall cohort (N = 522) | Unilateral (n = 378) | Bilateral (n = 144) | Odds ratio | |
|---|---|---|---|---|
| Hospital stay (d) | 16 (12-24) | 16 (11-24) | .90 | |
| Primary outcome | ||||
| TNDs | 70 (19.6) | 35 (21.2) | 0.89 (0.54-1.43) | .63 |
| PNDs | 25 (7.0) | 17 (10.3) | 1.89 (0.97-3.59) | .054 |
| Other early clinical outcomes | ||||
| 30-d mortality | 16 (4.5) | 24 (14.5) | 4.04 (2.10-7.92) | <.001 |
| Extracorporeal membrane oxygenation | 3 (0.8) | 10 (6.1) | 9.33 (2.81-42.1) | <.001 |
| Re-exploration for bleeding | 25 (7.0) | 14 (8.5) | 1.03 (0.48-2.08) | .93 |
| Reintubation | 9 (2.5) | 14 (8.5) | 3.65 (1.57-8.75) | .003 |
| Tracheostomy | 4 (1.1) | 3 (1.8) | 1.05 (0.15-4.94) | .95 |
| Renal failure | 24 (6.7) | 14 (8.5) | 1.40 (0.68-2.78) | .35 |
Values are presented as median (interquartile range) or n (%). CI, Confidence interval; TNDs, transient neurologic deficits; PNDs, permanent neurologic deficits.
Results from the patients with unilateral anterior cerebral perfusion group are references.
Adjusted early clinical outcomes depending on the types of cerebral perfusion techniques (intention-to-treat groups)
| Overall cohort (N = 188) | Unilateral (n = 94) | Bilateral (n = 94) | Odds ratio | |
|---|---|---|---|---|
| Hospital stay (d) | 16 (12-22) | 15 (12-20) | .50 | |
| Primary outcome | ||||
| TNDs | 19 (20.2) | 17 (18.1) | 0.87 (0.42-1.81) | .71 |
| PNDs | 8 (8.5) | 11 (11.7) | 1.42 (0.55-3.85) | .47 |
| Other early clinical outcome | ||||
| 30-d mortality | 7 (7.4) | 14 (14.9) | 2.18 (0.86-5.99) | .11 |
| Extracorporeal membrane oxygenation | 2 (2.1) | 6 (6.4) | 3.14 (0.70-21.8) | .17 |
| Re-exploration for bleeding | 10 (10.6) | 6 (6.4) | 0.57 (0.19-1.61) | .30 |
| Reintubation | 2 (2.1) | 7 (7.4) | 3.70 (0.87-25.3) | .11 |
| Tracheostomy | 0 | 1 (1.1) | NA | |
| Renal failure | 7 (7.4) | 11 (11.7) | 1.65 (0.62-4.67) | .33 |
Values are presented as median (interquartile range) or n (%). CI, Confidence interval; TNDs, transient neurologic deficits; PNDs, permanent neurologic deficits.
Results from the patients with unilateral anterior cerebral perfusion group are references.
Baseline characteristics depending on type of cerebral perfusion technique (as-treated groups)
| Variable | Overall cohort | Propensity-score matched cohort | ||||||
|---|---|---|---|---|---|---|---|---|
| Unilateral (n = 357) | Bilateral (n = 165) | STD | Unilateral (n = 112) | Bilateral (n = 112) | STD | |||
| Characteristic | ||||||||
| Age (y) | 60.6 ± 15.6 | 61.6 ± 13.4 | .47 | 0.07 | 61.5 ± 15.5 | 61.4 ± 13.6 | .96 | 0.007 |
| Male gender | 193 (54.1) | 77 (46.7) | .14 | 0.15 | 57 (50.9) | 58 (51.8) | >.99 | 0.018 |
| Hypertension | 215 (60.2) | 108 (65.5) | .30 | 0.11 | 73 (65.2) | 76 (67.9) | .78 | 0.155 |
| Diabetes mellitus | 36 (10.1) | 11 (6.7) | .27 | 0.12 | 9 (8.0) | 9 (8.0) | >.99 | 0 |
| Cerebrovascular disease | 22 (6.2) | 17 (10.3) | .14 | 0.15 | 10 (8.9) | 10 (8.9) | >.99 | 0 |
| Chronic renal failure | 14 (3.9) | 4 (2.4) | .54 | 0.09 | 3 (2.8) | 3 (2.8) | >.99 | 0 |
| Coronary artery disease | 15 (4.2) | 8 (4.8) | .92 | 0.03 | 4 (3.6) | 5 (4.5) | >.99 | 0.045 |
| Marfan syndrome | 24 (6.7) | 9 (5.5) | .72 | 0.05 | 7 (6.2) | 6 (5.4) | >.99 | 0.04 |
| DeBakey type 1 | 281 (78.7) | 131 (79.4) | .95 | 0.02 | 87 (77.7) | 90 (80.4) | .74 | 0.07 |
| DeBakey type 2 | 76 (21.3) | 34 (20.6) | .95 | 0.02 | 25 (22.3) | 22 (19.6) | .74 | 0.07 |
| Intramural hematoma | 77 (21.6) | 29 (17.6) | .35 | 0.10 | 23 (21.7) | 17 (16.0) | .38 | 0.05 |
| Hemopericardium | 130 (36.4) | 55 (33.3) | .56 | 0.07 | 23 (20.5) | 21 (18.8) | .87 | 0.12 |
| Details of surgery | ||||||||
| Arch surgery, n (%) | <.001 | 0.54 | .26 | 0.008 | ||||
| 1-partial arch replacement | 59 (16.5) | 21 (12.7) | 26 (23.2) | 15 (13.4) | ||||
| 2-partial arch replacement | 105 (29.4) | 32 (19.4) | 26 (23.2) | 29 (25.9) | ||||
| Total arch replacement | 159 (44.5) | 53 (32.1) | 43 (38.4) | 45 (40.2) | ||||
| Root surgery | .79 | 0.04 | .82 | 0.06 | ||||
| None | 318 (89.1) | 149 (90.3) | 12 (10.7) | 10 (8.9) | ||||
| Bentall's operation | 28 (7.8) | 13 (7.9) | 10 (8.9) | 7 (6.2) | ||||
| Valve sparing techniques | 11 (3.1) | 3 (1.8) | 2 (1.8) | 3 (2.7) | ||||
| Graft insertion in DTA | 19 (5.3) | 13 (7.9) | .16 | 0.23 | 12 (10.7) | 11 (9.8) | .69 | 0.11 |
| Years at operation | <.001 | 0.63 | .93 | 0.05 | ||||
| Quartile range 1 | 67 (18.8) | 63 (38.2) | 34 (30.4) | 36 (32.1) | ||||
| Quartile range 2 | 84 (23.5) | 46 (27.9) | 34 (30.4) | 33 (29.5) | ||||
| Quartile range 3 | 90 (25.2) | 41 (24.8) | 27 (24.1) | 29 (25.9) | ||||
| Quartile range 4 | 116 (32.5) | 15 (9.1) | 17 (15.2) | 14 (12.5) | ||||
| Surgeon | <.001 | 0.61 | .36 | |||||
| A | 347 (97.2) | 124 (75.2) | 107 (95.5) | 109 (97.3) | ||||
| B | 7 (2.0) | 33 (20.0) | 3 (2.7) | 3 (2.7) | ||||
| C | 3 (0.8) | 8 (4.8) | 2 (1.8) | 0 | ||||
Values are presented as mean ± SD or n (%). STD, Standardized mean difference; DTA, descending thoracic aorta.
Adjusted early clinical outcomes depending on the type of cerebral perfusion technique (as-treated groups)
| Overall cohort (N = 224) | Unilateral (n = 112) | Bilateral (n = 112) | Odds ratio | |
|---|---|---|---|---|
| Hospital stay (d) | 23.9 ± 27.3 | 23.7 ± 23.7 | .94 | |
| Primary outcome | ||||
| TNDs | 15 (13.4) | 26 (23.2) | 2.10 (0.72-6.93) | .19 |
| PNDs | 5 (4.5) | 10 (8.9) | 1.96 (0.98-4.01) | .06 |
| Other early clinical outcome | ||||
| 30-d mortality | 3 (2.7) | 11 (9.8) | 3.96 (1.20-17.9) | .04 |
| Extracorporeal membrane oxygenation | 0 | 5 (4.5) | NA | |
| Re-exploration for bleeding | 11 (9.8) | 10 (8.9) | 0.90 (0.36-2.23) | .82 |
| Reintubation | 3 (2.7) | 8 (7.1) | 2.79 (0.78-13.0) | .14 |
| Tracheostomy | 2 (1.8) | 2 (1.8) | 1.0 (0.12-8.45) | >.99 |
| Renal failure | 10 (8.9) | 11 (9.8) | 1.11 (0.45-2.78) | .82 |
Values are presented as mean ± SD or n (%). CI, Confidence interval; TNDs, transient neurologic deficits; PNDs, permanent neurologic deficits; NA, not available.
Results of unilateral cerebral perfusion group are references.
Figure E1Propensity score matched Kaplan-Meier plot for survival rates for the as-treated types of cerebral perfusion techniques. Solid red line indicates unilateral group; dashed blue line indicates bilateral group. Shaded bands indicate areas within 95% CIs. Bi-ACP, Bilateral antegrade cerebral perfusion; Uni-ACP, unilateral antegrade cerebral perfusion; HR, hazard ratio; CI, confidence interval.
Multivariable risk analyses for PND or 10-year mortality
| Variable | Univariable | Multivariable | ||
|---|---|---|---|---|
| Odds ratio (95% CI) | Odds ratio (95% CI) | |||
| PND | ||||
| Bilateral antegrade cerebral perfusion | 1.89 (0.97-3.59) | .054 | ||
| Intramural hematoma | 0.39 (0.11-1.00) | .08 | ||
| Hemopericardium | 1.56 (0.82-2.95) | .17 | ||
| Age | 1.02 (1.00-1.04) | .12 | ||
Bold indicates variables mentioned in the “Risk Factors for Permanent Neurologic Deficit and Mortality” section. PND, Permanent neurologic deficit.
The surgeon experience was graded depending on the surgical volumes (more experienced surgeon was scored as the higher number).
Figure 3Of 522 surgical repairs for acute type A aortic dissection, 357 unilateral and 165 bilateral antegrade cerebral perfusion techniques were used in the purpose of cerebral protection. In adjusted analysis using propensity score, 94 pairs of each group were matched. There was no significant difference in the early clinical outcomes and mortality rates.